Industry Spotlight

Chair of AusBiotech (WA Branch) named new PharmAust CEO

2 March 2016 via Biotech Dispatch: Dr Richard Hopkins, Chair of Ausbiotech (WA Branch), has been appointed to the role of Chief Executive Officer at PharmAust (ASX:PAA). Dr Hopkins is an experienced pharmaceutical executive with over 10 years in corporate leadership... | READ MORE

New Chairman for Actinogen Medical

2 March 2016 via Biotech Dispatch: Actinogen Medical (ASX:ACW) has announced the appointment of healthcare industry and venture capital veteran, Dr Geoff Brooke, as Chairman, effective 1 March. The appointment adds significant life science and financial expertise to... | READ MORE

Peter Mac joins BMS global immune-oncology network

28 February 2017 via Biotech Dispatch: The Melbourne-based Peter MacCallum Cancer Centre has become the first Australian representative on Bristol-Myers Squibbs International Immuno-Oncology Network. The peer-to-peer global network, comprised of 15 members including... | READ MORE

TGA approval for CSL Behring lung therapy

28 February 2017 via Biotech Dispatch: The TGA has approved CSL Behrings ZEMAIRA for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). AATD is a hereditary condition that can severely affect a patients lung function. The condition is marked by a low level or a... | READ MORE

WA Labor commits to Medical Research Future Fund

23 February 2017 via Biotech Dispatch: WA Labor has committed to invest interest generated from the states $1 billion Future Fund in medical research. The commitment comes just weeks before the 11 March state election at which the ruling Liberal government led by Co... | READ MORE

Orthocell reports initial results from CelGro trial

23 February 2017 via Biotech Dispatch: Regenerative medicine company Orthocell (ASX:OCC) has announced positive initial safety and tolerability results for its CelGro collagen-based medical device, in a clinical study examining its use to augment the repair of nerve ... | READ MORE

Australia and NZ sign innovation treaty

21 February 2017 via Biotech Dispatch: Australia and New Zealand have signed a new treaty focussed on science and innovation. Industry, innovation and science minister Senator Arthur Sinodinos and his New Zealand counterpart, Simon Bridges, signed the treaty-level S... | READ MORE

Immuron completes trial recruitment

21 February 2017 via Biotech Dispatch: Immuron (ASX IMC) has announced its IMM-124E Phase 2 clinical trial for the treatment of NASH (Non-Alcoholic Steatohepatitis) has successfully reached its full recruitment milestone of 120 randomised patients. Immuron is focuse... | READ MORE

Support for innovation - real or rhetoric?

16 February 2017 via Biotech Dispatch: The Turnbull governments approach to innovation will be tested in the months ahead. Is it real or just rhetoric? Malcolm Turnbull replaced Tony Abbott as prime minister in 2015 and actively promoted innovation as fundamental to... | READ MORE

Government announces appointment of cannabis advisory council

16 February 2017 via Biotech Dispatch: Health minister Greg Hunt has announced the appointment of members to the Australian Advisory Council on the Medicinal Use of Cannabis - which will provide expert advice to government. Government is working towards enabling the... | READ MORE

Jump to page